The present invention relates to compounds and pharmaceutical compositions useful for treating pain. The invention also relates to methods of treating or alleviating pain in mammals, comprising administering to a mammal suffering from pain, a pain-alleviating amount of a compound of the general formula (I) or (II).
This application is a national phase application (35 U.S.C. .sctn. 371) of International Application No. PCT/IL02/00502 filed Jun. 24, 2002, which is a continuation-in-part of U.S. patent application Ser. No. 09/888,958, filed Jun. 25, 2001, now U.S. Pat. No. 6,518,311, which is a continuation-in-part of U.S. patent application Ser. No. 09/462,533, filed Apr. 11, 2000, now U.S. Pat. No. 6,251,946, which is a national phase of International Application No. PCT/IL98/00316 filed on Jul. 7, 1998.
